Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I

scientific article published on 27 June 2002

Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M205258200
P698PubMed publication ID12089155

P2093author name stringBrian C Yowler
Cara-Lynne Schengrund
Richard D Kensinger
P433issue36
P407language of work or nameEnglishQ1860
P921main subjectneuroblastomaQ938205
P1104number of pages5
P304page(s)32815-32819
P577publication date2002-06-27
P1433published inJournal of Biological ChemistryQ867727
P1476titleBotulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I
P478volume277

Reverse relations

cites work (P2860)
Q47151324A Cell Line for Detection of Botulinum Neurotoxin Type B.
Q37357100A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies
Q35669634An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.
Q33869062Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors
Q28485303Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay
Q36511574Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting
Q34583087Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1
Q38224215Botulinum neurotoxins: genetic, structural and mechanistic insights.
Q39039170Botulinum protease-cleaved SNARE fragments induce cytotoxicity in neuroblastoma cells
Q34995583Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a
Q40265665Characterization of Clostridial botulinum neurotoxin channels in neuroblastoma cells
Q82643022Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination
Q27651618Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction
Q92690319Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside
Q36389297Designer probiotics for prevention of enteric infections.
Q79479284Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties
Q26859917Emerging opportunities for serotypes of botulinum neurotoxins
Q36611014Entering neurons: botulinum toxins and synaptic vesicle recycling
Q40442566Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons
Q34702285Evidence That Botulinum Toxin Receptors on Epithelial Cells and Neuronal Cells Are Not Identical: Implications for Development of a Non-Neurotropic Vaccine
Q48462023Expression and function of SNAP-25 as a universal SNARE component in GABAergic neurons.
Q27656415Gangliosides as High Affinity Receptors for Tetanus Neurotoxin
Q35932883Glycosphingolipids-sweets for botulinum neurotoxin
Q27655649Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F
Q36992893Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
Q37274652Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A
Q34733600Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).
Q84743055Low pH-induced pore formation by the T domain of botulinum toxin type A is dependent upon NaCl concentration
Q44555884Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect
Q36364296Model for studying Clostridium botulinum neurotoxin using differentiated motor neuron-like NG108-15 cells
Q38080382Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function
Q89583750Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors
Q36818335Progress in cell based assays for botulinum neurotoxin detection
Q35772134Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery
Q37408530Receptor and substrate interactions of clostridial neurotoxins
Q37843686Receptor mimicry as novel therapeutic treatment for biothreat agents
Q38696776SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E.
Q110866263Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
Q39157207Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells
Q27643302Structural basis of cell surface receptor recognition by botulinum neurotoxin B
Q27677003Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D
Q35187559The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions
Q36085668The evolving field of biodefence: therapeutic developments and diagnostics
Q28609177The journey of tetanus and botulinum neurotoxins in neurons
Q57157766Variability of Botulinum Toxins: Challenges and Opportunities for the Future
Q57808978Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
Q34516235Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes
Q61797224Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?

Search more.